Literature DB >> 29862428

Central 10-degree visual field change following non-penetrating deep sclerectomy in severe and end-stage glaucoma: preliminary results.

Igor Leleu1, Benjamin Penaud2, Esther Blumen-Ohana2, Thibault Rodallec2, Raphaël Adam2, Olivier Laplace2, Jad Akesbi2, Jean-Philippe Nordmann2.   

Abstract

PURPOSE: To report the impact of non-penetrating deep sclerectomy (NPDS) in severe and end-stage glaucoma treatment on the central 10° visual field progression (mean deviation, four central points, foveal threshold) and assess the risk of sudden visual loss.
METHODS: Monocenter database study. We reviewed records of 34 eyes with severe or end-stage glaucoma that underwent NPDS between 2009 and 2015, at the National Ophthalmology Center of XV-XX (Paris, France). Severe and end-stage glaucoma were defined according to the Bascom Palmer Modified Glaucoma Staging System classification. All eyes had a constricted visual field < 10° (severe injury by the Humphrey visual field automated (HVFA) 10-2). Visual fields were recorded every 6 months after the procedure. Data from the last visit was used for the statistical analysis.
RESULTS: The mean follow-up duration was 29 months (range 6 to 54) and 33 (97%) eyes were followed for more than 1 year. There were no cases of postoperative sudden visual loss. The intraocular pressure (IOP) decreased from 21.9 ± 8.1 to 15.0 ± 5.4 mmHg (P < .001). Twenty-eight (82%) eyes had an IOP < 21 mmHg and 19 (56%) an IOP < 16 mmHg. The MD 10-2 remained stable (- 19.8 ± 7.4 to - 19.4 ± 8.1 dB, non-significant improvement of + 0.4 dB, P = .1). The MD 10-2 slope showed an insignificant improvement of + 0.25 ± 1.8 dB per year (dB/y) (P = 0.1), but this slope was significantly better when the IOP was reduced to < 16 mmHg than when the IOP was ≥ 16 mmHg at the last visit (+ 0.84  1.2 versus - 0.48 ± 2.2 dB/y, P = .05). The mean number of the four central test points with sensitivity ≤ 5 dB and the change in mean sensitivity of the four central field points remained stable. There were no significant changes in the VFI (from 25.4% ± 13 to 25.8% ± 20) and in foveal threshold.
CONCLUSION: NPDS appears to provide stability of the central 10° visual field (with a trend towards improvement but non-significant) with no occurrence of "wipe-out" phenomenon and few other complications. Consideration of NPDS in end-stage and severe glaucoma is advisable given its low risk of complications and its considerable IOP decrease with a relative stability of the central visual field.

Entities:  

Keywords:  Deep sclerectomy; End-stage glaucoma; Filtering surgery; Humphrey visual field; Sudden visual loss

Mesh:

Year:  2018        PMID: 29862428     DOI: 10.1007/s00417-018-4025-6

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  35 in total

1.  Use of a central 10 degrees field and size V stimulus to evaluate and monitor small central islands of vision in end stage glaucoma.

Authors:  A H Zalta
Journal:  Br J Ophthalmol       Date:  1991-03       Impact factor: 4.638

2.  Wipe-out: a complication of glaucoma surgery or just a blast from the past?

Authors:  Marlene R Moster; Mark L Moster
Journal:  Am J Ophthalmol       Date:  2005-10       Impact factor: 5.258

3.  Managing advanced unilateral pseudoexfoliative glaucoma.

Authors:  André Marques
Journal:  BMJ Case Rep       Date:  2014-05-21

4.  Non-penetrating deep sclerectomy and collagen implant surgery in glaucoma patients with advanced field loss.

Authors:  H Ates; K Andac; O Uretmen
Journal:  Int Ophthalmol       Date:  1999       Impact factor: 2.031

5.  The impact of surgical intraocular pressure reduction on visual function using various criteria to define visual field progression.

Authors:  Namita Bhardwaj; Philip I Niles; David S Greenfield; Maggie Hymowitz; Mitra Sehi; William J Feuer; Donald L Budenz
Journal:  J Glaucoma       Date:  2013 Oct-Nov       Impact factor: 2.503

6.  Reliability of visual field results over repeated testing.

Authors:  J Katz; A Sommer; K Witt
Journal:  Ophthalmology       Date:  1991-01       Impact factor: 12.079

7.  Risk of sudden visual loss following filtration surgery in end-stage glaucoma.

Authors:  Fotis Topouzis; Paris Tranos; Archimidis Koskosas; Theofanis Pappas; Eleftherios Anastasopoulos; Stavros Dimitrakos; M Roy Wilson
Journal:  Am J Ophthalmol       Date:  2005-10       Impact factor: 5.258

8.  Long-term outcome following trabeculectomy: II Visual field survival.

Authors:  V Popovic; J Sjöstrand
Journal:  Acta Ophthalmol (Copenh)       Date:  1991-06

9.  Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group.

Authors: 
Journal:  Am J Ophthalmol       Date:  1998-10       Impact factor: 5.258

10.  Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.

Authors:  Anders Heijl; M Cristina Leske; Bo Bengtsson; Leslie Hyman; Boel Bengtsson; Mohamed Hussein
Journal:  Arch Ophthalmol       Date:  2002-10
View more
  2 in total

1.  Long term outcomes of cataract surgery in severe and end stage primary angle closure glaucoma with controlled IOP: a retrospective study.

Authors:  Lin Fu; Yau Kei Chan; Junhua Li; Li Nie; Na Li; Weihua Pan
Journal:  BMC Ophthalmol       Date:  2020-04-19       Impact factor: 2.209

2.  Cataract and glaucoma combined surgery: XEN® gel stent versus nonpenetrating deep sclerectomy, a pilot study.

Authors:  Vincent Theillac; Esther Blumen-Ohana; Jad Akesbi; Pascale Hamard; Alexandre Sellam; Emmanuelle Brasnu; Christophe Baudouin; Antoine Labbe; Jean-Philippe Nordmann
Journal:  BMC Ophthalmol       Date:  2020-06-16       Impact factor: 2.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.